September 9, 2020 Life Science Tools Product Launch

PCR Biosystems launches RiboShield™ RNase Inhibitor to ensure reliable RNA protection

Caption: RiboShield™ RNase Inhibitor. Click images to download.  London, UK (09 September 2020) — PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product. RiboShield™ RNase Inhibitor is a recombinant protein that blocks the activity of a... Read more

September 8, 2020 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Life Science Tools

FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer

FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO CARLSBAD, Calif., Sept. 8, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a... Read more

August 25, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19

Easy-to-Administer Saliva Test for COVID-19 Available for Immediate Shipment Extraction-Free, Real-Time PCR Workflow with Capacity of up to 6,000 Tests per Day per System Demonstrated 100 Percent Agreement with Authorized Nasopharyngeal Assays SOUTH SAN FRANCISCO, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight,... Read more

August 19, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Granted CE IVD Mark for Quick SARS-CoV-2 rRT-PCR Kit

IRVINE, Calif., (Aug. 19, 2020) — Zymo Research announced that it was recently granted the CE IVD Mark for its Quick SARS-CoV-2 rRT-PCR Kit. To obtain this certification the product had to comply with the Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. The Quick SARS-CoV-2 rRT-PCR Kit is... Read more

August 19, 2020 Life Science Tools M&A, Partnerships

Bio-Techne Corporation and Leica Biosystems Are Accelerating Disease Research With RNAscope Covid-19 Probes and the Bond Rx*

AUGUST 19, 2020 Research-use-only RNA-ISH probes now available for COVID-19 on our automated platform MINNEAPOLIS, Aug. 19, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), in partnership with Leica Biosystems, today announced the automation of RNAscope™ COVID-19 probes on BOND RX*, Leica’s staining platform, for research use only. Researchers now have the ability to automate their COVID-19 research protocols,... Read more

August 18, 2020 Atomic Spectroscopy Informatics & Software Life Science Tools

QIAGEN expands integrated coronavirus NGS and software solutions to accelerate COVID-19 research  

Hilden, Germany, and Germantown, Maryland, August 18, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) launched the innovative QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing (NGS) of the novel coronavirus genome, along with integrated analysis and interpretation workflows for insights into the evolution and spread of the virus that causes COVID-19 disease. The new... Read more

August 17, 2020 Life Science Tools Product Launch

Swift Biosciences Expands Coronavirus Research With ACE2 Swift Normalase Amplicon Panel

(ANN ARBOR, MICH.  August 17, 2020) Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits recently launched a new ACE2 Swift Normalase® Amplicon Panel (SNAP) to further research on the main functional receptor for viral entry of Coronavirus. With global numbers of COVID-19 cases increasing, Swift remains committed to providing... Read more

August 11, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Bio-Techne Announces Release of a New SARS-CoV-1/2 Spike RBD Llamabody Recombinant Antibody That Blocks Viral Entry

MINNEAPOLIS, Aug. 11, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds to the SARS-CoV-2 spike receptor binding domain (RBD) and blocks the virus from binding to its host receptor, ACE-2, inhibiting viral infection . The SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody is the... Read more

August 6, 2020 Life Science Tools M&A, Partnerships

Bio-Techne and Nanostring Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler

Curated Menu of Off-the-Shelf RNAscope Probes Provide Molecularly-Guided Region of Interest Selection for Use with the New NGS-Enabled Cancer Transcriptome Atlas MINNEAPOLIS and SEATTLE, Aug. 6, 2020 /PRNewswire/ — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic markets and NanoString Technologies, Inc. (NASDAQ:NSTG), a leading... Read more

August 3, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne and Kantaro Biosciences to Launch a Quantitative Research Use Only COVID-19 Serology Test

MINNEAPOLIS and NEW YORK, Aug. 3, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit. Bio-Techne and Kantaro will leverage a joint commercialization and distribution team... Read more